Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Medical daily | Rare Historical Photos

First-in-Class Drug Targeting Treatment-Resistant High Blood Pressure Wins FDA Approval — and Works Like No Existing Drug

FDA approved baxdrostat (Baxfendy) on May 18, 2026 as the first-ever oral aldosterone synthase inhibitor for uncontrolled and resistant hypertension. BaxHTN Phase 3 (NEJM 2025): 8.7–9.8 mmHg additional systolic blood pressure reduction added to background therapy. Here is the full story.

Medical Daily

Meningococcal Cases Reach Second-Highest Level in Over a Decade as Drug-Resistant Strain Disproportionately Hits Black Americans

CDC surveillance data (updated June 2026): 463 meningococcal disease cases in 2025 — the second-highest annual count since 2014. The dominant ST-1466 strain is drug resistant and disproportionately kills Black adults ages 30–60 and people with HIV. Here is the full picture.

Medical Daily

A New Antibiotic That Defeats Superbugs Just Received FDA Approval for Dangerous Drug-Resistant Urinary Tract Infections

FDA approved Zaynich (cefepime and zidebactam) on May 29, 2026 for complicated urinary tract infections caused by drug-resistant Gram-negative pathogens. ENHANCE-1 Phase 3 trial showed superiority to meropenem at test of cure. Here is how it works and who benefits.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Largest US Study of PFAS-Exposed Communities Confirms Serious Health Risks in Children and Adults

The ATSDR published the first large-scale US clinical study of health outcomes in PFAS-contaminated drinking water communities in June 2026, enrolling 8 sites across 8 states. The study found liver, thyroid, kidney, immune, and cardiometabolic damage — coming as EPA proposes rolling back PFAS drinking water limits.

Medical Daily

Rocky Mountain Spotted Fever Kills Within Days and Is Frequently Mistaken for Flu — Tick Season 2026 Is a Critical Window to Know the Warning Signs

Rocky Mountain spotted fever kills 5–10% of patients even with treatment and can be fatal within 3–5 days. Peak season runs May through August. A February 2026 CDC EID study documents 19.8% fatality in pediatric cases. Doxycycline must be started before test results. Here is the full warning.

Medical Daily

Yellow Fever Colombia 2026 Outbreak: 76 Dead Since 2024 with Case Fatality Rate Exceeding 70 Percent as CDC Issues Active Level 2 Travel Notice

Yellow fever in Colombia has killed 76 people since 2024, with case fatality rates exceeding 40–70% in some periods. 35 cases and 18 deaths in 2026 alone. Venezuela also reports an active outbreak. CDC Level 2 travel notice covers Colombia and South America. Here is what travelers need to know.

Medical Daily

CRISPR Gene Editing Achieves a Functional Cure for Sickle Cell Disease in 96 Percent of Patients — RUBY Trial Results in the New England Journal of Medicine Are Historic

The RUBY Trial (NEJM, April 2026): CRISPR-Cas12a gene editing therapy reni-cel (renizgamglogene autogedtemcel) achieved a functional cure in 27 of 28 (96%) severe sickle cell disease patients, with no painful crises for up to two years after treatment. Led by Dr. Rabi Hanna at Cleveland Clinic.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Counterfeit Botox Injections Are Sending People to Hospitals in Multiple U.S. States — and the CDC Warns the Risk Is Ongoing

The CDC has an active warning about harmful and potentially fatal reactions from counterfeit Botox and mishandled botulinum toxin injections, documented across multiple U.S. states. A 2024 investigation found 22 hospitalizations, including 4 on ventilators. The CDC warning remains active in 2026.

Medical Daily

Alzheimer's Disease Is No Longer Untreatable: A 2026 Guide to the Blood Tests, Drugs, and Prevention Strategies That Are Changing the Future for 7 Million Americans

A comprehensive June 2026 guide to Alzheimer's prevention and treatment: two FDA-approved disease-modifying drugs (lecanemab/Leqembi, donanemab/Kisunla), an FDA-cleared blood test (Lumipulse pTau217), and the lifestyle interventions with the strongest prevention evidence.

Medical Daily

The CDC Now Recognizes Chagas Disease as Endemic in the United States — and an Estimated 300,000 Americans May Have It Without Knowing

The CDC's September 2025 Emerging Infectious Diseases study confirms Chagas disease should be recognized as endemic in the U.S. with human cases in 8 states and kissing bugs in 32. An estimated 300,000 Americans are living with it — most undiagnosed. Here is what residents in the South and Southwest…

Medical Daily

Lassa Fever Nigeria 2026: 663 Confirmed Cases, 167 Deaths, 25 Percent Fatality Rate as US Healthcare Experts Issue Urgent Warning to Travelers

Nigeria's 2026 Lassa fever outbreak: 663 confirmed cases, 167 deaths, 25.2% case fatality rate — up from 18.5% last year — across 22 states. 39 healthcare workers infected. NETEC warns U.S. clinicians to increase suspicion in returning travelers. Here is what patients and providers need to know.

Medical Daily

ByHeart Infant Formula Botulism Outbreak Post-Investigation 2026: Root Cause Still Unidentified Despite Genetic Match to Milk Powder Supplier

The FDA and CDC declared the ByHeart infant formula botulism outbreak over on February 26, 2026 after 48 infants were sickened across 17 states. A June 10, 2026 Food Safety Magazine investigation reveals the root cause remains unidentified despite genetic matches to organic whole milk powder. New testing protocols are…

Medical Daily

Hepatitis A Outbreak in Canada Leaves 4 Dead, 142 Hospitalized; CDC Issues Travel Notice as Many Americans Traveling to Canada Remain Unvaccinated.

The CDC issued a hepatitis A travel notice for Manitoba, Canada on June 4, 2026. The outbreak has grown to 658 cases, 142 hospitalizations, and 4 deaths since April 2025. Winnipeg restaurant exposures have been identified. Here is what U.S. travelers need to know before visiting Canada.

Medical Daily

AI Outpaces Trust in Healthcare as Patients and Doctors Struggle to Keep Up, 2026 Study Finds

The 2026 Future Health Index found AI is transforming clinical care, but trust gaps among doctors and patients are slowing adoption and threatening patient safety.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Eli Lilly's $2.75 Billion AI Bet on Anti-Aging Drugs Signals a Major Shift in Pharmaceutical Priorities

Eli Lilly's $2.75B AI deal with Insilico Medicine targets age-related diseases. How AI is transforming longevity drug discovery and what it means for patients.

Medical Daily

AI Scribing Tools Cut Physician Burnout by Over 21 Percent, Major U.S. Hospital Study Finds

A Mass General Brigham and UCLA study found AI ambient scribes cut physician burnout by 21%, freeing doctors for patient care. Here's what the research shows.

Medical Daily

Mount Sinai Scientists Reverse Aging in Blood Stem Cells by Fixing the Cell's Recycling System

Mount Sinai scientists reversed aging in blood-forming stem cells in mice by restoring lysosomal function, opening doors to blood disorder and cancer prevention.

Medical Daily

FDA Clears First Human Epigenetic Reprogramming Trial in U.S. — What the Harvard-Backed Anti-Aging Therapy Could Mean for You

Harvard-backed Life Biosciences has received FDA clearance for the first-ever human epigenetic reprogramming trial. Here's what it targets and why it matters.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Deadly New Sedative Found in Street Drugs Across 18 States; Experts Warn Naloxone Alone Cannot Reverse Its Effects

The CDC issued a Health Advisory on April 2, 2026 warning that medetomidine, a veterinary sedative, is now detected in fentanyl samples across 18 states and D.C. Detections rose 3,000% between 2023 and 2025. Naloxone does not reverse its effects, and withdrawal can cause life-threatening hypertension.

Medical Daily

The First Lyme Disease Vaccine in 24 Years Just Passed Its Pivotal Phase 3 Trial with 74 Percent Efficacy — and It Is for Children Too

Pfizer and Valneva announced Phase 3 VALOR trial results for Lyme disease vaccine PF-07307405 on March 23, 2026: 73.2–74.8% efficacy in ages 5 and older. Regulatory submissions planned for 2026. No Lyme vaccine has been available in the U.S. since 2002.

Medical Daily

E. Coli Outbreak Linked to Beef Kofta at The Kebab Shop Hospitalizes 5 and Gives 2 Children Kidney Failure — Genetic Testing Confirms the Match

USDA FSIS public health alert (May 24, 2026) and genetic confirmation (June 1, 2026): E. coli O157:H7 outbreak linked to beef kofta at The Kebab Shop in California. Nine sick, five hospitalized, two children with HUS. Olympia Foods confirmed as source.

Medical Daily

Diphtheria Outbreak 2026: CDC Issues New Sub-Saharan Africa Travel Alert Covering 7 Countries with Over 20,000 Cases and 1,252 Deaths in 2025

The CDC issued a new diphtheria travel alert for Chad, Guinea, Niger, Nigeria, Mali, Mauritania, and Somalia on June 2, 2026. WHO documented 20,412 suspected cases and 1,252 deaths in Africa in 2025. Here is what travelers and unvaccinated Americans need to know.

Medical Daily

FDA Set to Rule on First New Smoking Cessation Drug in 20 Years: Cytisinicline Decision Due June 20

Cytisinicline, a plant-based alkaloid for smoking cessation, has an FDA PDUFA date of June 20, 2026 — 8 days away. If approved, it would be the first new quit-smoking drug in 20 years. Phase 3 ORCA-2 and ORCA-3 trials showed significantly higher quit rates than placebo.

Medical Daily

Invasive Group A Strep Remains at Near-Record Levels in 2026, and Homeless Shelters Are Now Documented Outbreak Amplifiers, CDC Reports

Invasive Group A Streptococcus (iGAS) hit a 20-year high in 2023 and remains elevated in 2026. A new CDC Emerging Infectious Diseases study (June 2026) documents a shelter-linked outbreak in Chicago with 41 cases and 2 deaths. Here is the full picture.

Medical Daily

Mpox Clade I Has Spread Beyond Africa and Is Now Circulating Locally in Europe. The CDC Expects More U.S. Cases — and the Vaccine Gap Is Getting Harder to Ignore.

More than 20 clade I mpox cases have been confirmed in the U.S. as of June 2026. The CDC now expects additional cases as local clade Ib transmission has been detected in Europe among men who have sex with men with no travel history to Africa. JYNNEOS vaccine uptake lags…

1 2 3 4 5

Organisations

The National Institutes of Health

the New England Journal of Medicine

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.